LONDON
TechNavio has announced the publication of a new market research report on the Osteoporosis Drugs Market in APAC Region, which is expected to grow at a CAGR of 4.73 percent from 2015-2019.
According to the new report, enhanced patient and physician awareness has been leading to greater drug penetration. Additionally, institutions like the National Osteoporosis Foundation are dedicated to the prevention of osteoporosis and fractures.
“In the US, May is celebrated as National Osteoporosis Awareness and Prevention month. Such initiatives are increasing the awareness of bone health among the general population,” says Faisal Ghaus, Vice President of TechNavio.
Furthermore, the paradigm shift from antiresorptive therapies to anabolic drugs is also expected to propel the overall market growth. Treatments for osteoporosis, which haven’t evolved much in the past 20 years, will see a major overhaul with the launch of new efficacious and safe anabolic treatments.
“Three late-stage pipeline products, romosozumab, BA-058 and oral PTH have been found to be highly effective in increasing bone mineral density (BMD) by almost double the amount as compared to current treatment options,” says Ghaus.
Key Information Covered in the Report:
- Market segmentation, size and forecast through 2019
- Market Growth Drivers:
- Increase in Aging Population
- For a full detailed list, view our report.
- Market Challenges:
- High Costs
- For a full detailed list, view our report.
- Market Trends:
- Increasing Awareness of Bone Health Education
- For a full detailed list, view our report.
- Key Vendors:
- Amgen Inc.
- Eli Lilly & Co.
- Merck & Co. Inc.
- Novartis AG
- Other Prominent Vendors:
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Jiangsu Hengrui Medicine
- Pfizer
TechNavio currently has more than 3000 market research reports on a huge range of topics, including 50+ reports on the osteoporosis drugs market:
If you are interested in more information, please contact our media team at media@technavio.com.
CONTACT
TechNavio Research
Jes Ellacott
US: +1 630-333-9501
UK:
+44 208 123 1770
Media & Marketing Executive
www.technavio.com
media@technavio.com
